Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Glaucoma is a complex condition of the eye. It is an ophthalmic neurodegenerative condition and is characterised by raised intraocular pressure. Glaucoma is caused by a number of different eye diseases that in most cases produce increased pressure within the eye. This elevated pressure is caused by a backup of fluid in the eye. Over time, it causes damage to the optic nerve. As per the World Health Organization (WHO), glaucoma is the most cause of blindness across the world. The treatment for glaucoma starts with topical eye drops, which is an alternative used to delay surgery. Once glaucoma is detected, appropriate management can slow disease progression and save remaining vision, although lost vision cannot be restored. Therefore, early detection and appropriate management are essential to controlling the disease. In addition to lack of early symptoms, detection and management of glaucoma are challenged by difficulties in reaching high-risk populations and by the lack of simple, cost-effective screening plans
Rise in incidence of glaucoma, coupled with the availability of medical insurance coverage for diagnosis and treatment, growth in demand for minimally invasive glaucoma surgeries and growing geriatric population drives the market growth.
Moreover, the growth in focus of manufacturers on developing micro-invasive glaucoma drainage implants boost the market growth. According to The International Agency for the Prevention of Blindness, it has been estimated that by 2020 there will be approximately 80 million people with glaucoma, an increase of about 20 million since 2010. Furthermore, it is thought that at present over 3 million people are blind due to glaucoma, and this number is expected to reach 3.2 million by 2020 with the rising prevalence, unless improved screening and effective treatment strategies are successful. On the other hand, lack of awareness about glaucoma and the devices associated with it in certain developing and underdeveloped economies hampers this market growth.
The report analyses the global Glaucoma Surgery Devices based on product type, surgery type, end-user and geography.
Based on type, the global glaucoma surgery devices market is segmented into implants and stents, glaucoma drainage devices and glaucoma laser devices. Glaucoma drainage devices (GDD) occupy an important place in the surgical management of glaucoma that is not responding to medications and trabeculectomy operations. In certain conditions, such as neovascular glaucoma, pediatric glaucoma, iridocorneal endothelial syndrome, penetrating keratoplasty with glaucoma, glaucoma following retinal detachment surgery, it has become the preferred operation. The market growth of the segment is attributed to rise in preference of drainage devices such as Ahmed valves or aqueous shunts over conventional glaucoma surgeries.
Based on type, the global glaucoma surgery devices market is segmented into conventional glaucoma surgeries and minimally invasive glaucoma surgeries. The conventional glaucoma surgeries accounted for significant market share owing to the fewer complications associated with conventional glaucoma surgeries, making them the first choice of the surgeons for the treatment of certain types of glaucoma.
Based on end-user, the glaucoma market is segmented into hospitals, ophthalmic clinic, and ambulatory surgical centers. Hospitals segment is observed to be a more preferred choice for ophthalmic surgeries. Well-equipped hospitals are more favoured for ophthalmic surgeries than surgery centres, in case of any medical complications or emergency procedures. The geriatric population are also likely to prefer to do their surgeries in hospitals, out of safety concerns.
By geography, the global glaucoma surgery devices is studied across the countries of key regions such as, North America, Europe, Asia Pacific, and Rest of the world.
North America OVD market dominated the global market in 2018. The high growth of the region is attributed to due to the factors including growing geriatric populace coupled with the rising incidences of glaucoma and availability of wider treatment options coupled with healthcare facility and growing awareness. As indicated by Prevent Blindness America the overall national rate is 1.9% for the U.S. population age 40 and older, indicating that more than 2.7 million older Americans have primary open-angle glaucoma.
On the other hand, Asia-Pacific witnessed highest growth rate for glaucoma surgery devices market owing to the high population density and increase in geriatric population, growing medical tourism, increasing per capita income. Moreover, growth in incidence of congenital glaucoma in India and China boosts the market growth.
The major players involved in the global Glaucoma Surgery Devices market include Alcon, Inc. (Novartis AG), Glaukos Corporation, New World Medical, Inc., Ellex Medical Lasers Ltd., Abbott Medical Optics (Abbott Laboratories), Johnson & Johnson, Bausch & Lomb, Inc. (Valeant Pharmaceuticals International, Inc.), Topcon Corporation, Lumenis Ltd., and Allergan Plc. The key players operating in the glaucoma surgery devices market have adopted product launch as one of their key developmental strategy, among many others such as business expansion, and business acquisition, product development etc.
The report analyses the global glaucoma surgery devices based on product type, surgery type, end-user and geography. Based on type, the global glaucoma surgery devices market is segmented into implants and stents, glaucoma drainage devices and glaucoma laser devices. Further, by surgery type, the global glaucoma surgery devices market is segmented into conventional glaucoma surgeries and minimally invasive glaucoma surgeries. By geography, the global glaucoma surgery devices is studied across the countries of key regions such as, North America, Europe, Asia Pacific, and Rest of the world
Based on end-user, the glaucoma market is segmented into hospitals, ophthalmic clinic, and ambulatory surgical centers. The major players involved in the global Glaucoma Surgery Devices market include Alcon, Inc. (Novartis AG), Glaukos Corporation, New World Medical, Inc., Ellex Medical Lasers Ltd., Abbott Medical Optics (Abbott Laboratories), Johnson & Johnson, Bausch & Lomb, Inc. (Valeant Pharmaceuticals International, Inc.), Topcon Corporation, Lumenis Ltd., and Allergan Plc.
Why to buy this report:
